Common conditions of the aging male: Erectile dysfunction, benign prostatic hyperplasia, cardiovascular disease and depression

International Urology and Nephrology

Volumn 33, Issue 2, 2001, Pages 283-292

  Zakaria, Lara ^a   Anastasiadis, Aristotelis G ^a   Shabsigh, Ridwan ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ANDROGEN; CLOMIFENE CITRATE; DOXAZOSIN MESYLATE; ESTRADIOL; ESTROGEN RECEPTOR; FINASTERIDE; FOLLITROPIN; HIGH DENSITY LIPOPROTEIN; LUTEINIZING HORMONE; SILDENAFIL; TAMOXIFEN CITRATE; TAMSULOSIN; TERAZOSIN; TESTOSTERONE;

AGED; AGING; CARDIOVASCULAR DISEASE; CORRELATION ANALYSIS; DEPRESSION; ENDOSCOPIC SURGERY; ERECTILE DYSFUNCTION; GERIATRICS; HEALTH CARE COST; HUMAN; LIFE EXPECTANCY; MALE; MALE INFERTILITY; MORBIDITY; MORTALITY; PROSTATE HYPERTROPHY; PROSTATECTOMY; QUALITY OF LIFE; REVIEW; TRANSURETHRAL MICROWAVE THERMOTHERAPY; TRANSURETHRAL NEEDLE ABLATION; TRANSURETHRAL RESECTION; UROLOGY; IMPOTENCE; MIDDLE AGED;

AGED; AGING; ANDROGENS; CARDIOVASCULAR DISEASES; DEPRESSION; HUMAN; IMPOTENCE; MALE; MIDDLE AGE; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; HUMANS; MIDDLE AGED;

EID: 0035527537     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015292603884     Document Type: Review

References (77)

1. 'Age power': How the new-old will transform medicine in the 21st century
2. Population division, department of economic and social affairs
3. Successful aging
4. Andropause: A misnomer for a true clinical entity
5. The relationship between depression and erectile dysfunction
6. Risk versus benefits of testosterone therapy in elderly men
7. National Institute of Health Consensus Development Panel on impotence: Impotence
8. Economical aspects of erectile dysfunction
9. Incidence of erectile dysfunction in men 40 to 69 years old: Longitudinal results from the Massachusetts male aging study
10. Impotence on the rise as a urologic subspeciality
11. Epidemiology and natural history of erectile dysfunction: Risk factors including iatrogenic and aging
12. Erectile dysfunction and coronary risk factors: Prospective results from the Massachusetts male aging study
13. The nature of androgen action on male sexuality: A combined laboratory-self report study on hypogonadal men
14. The role of androgens in the erectile response: A 1999 perspective
15. Prevalence of lower urinary tract symptoms and self-reported diagnosed 'benign prostatic hyperplasia', and their effect on quality of life in a community-based survey of men in the UK
16. Epidemiology of benign hyperplasia: Risk factors and concomitance with hypertension
17. Clinical and experimental studies of benign prostatic hyperplasia
18. Clinical and biological characteristics of familial benign prostatic hyperplasia
19. BPH and sexuality
20. Experience with testosterone replacement in the elderly
21. Testosterone decreases lipoprotein(a) in men
22. Testosterone-induced suppression of lipoprotein(a) in normal men; Relation to basal lipoprotein(a) level
23. Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants
24. The association of hypotestosteronemia with coronary artery disease in men
25. Sex hormones and lipoproteins in men
26. Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms
27. The recognition and treatment of depression in older people in primary care
28. Clinical detection of depression among community-based elderly people with self-reported symptoms of depression
29. Depression late in life: How to treat patients with comorbid chronic illness
30. Minor and major depression and the risk of death in older persons
31. Increased mortality rates in late-life depression
32. Depression is a risk factor for non-compliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence
33. The relationship between depression and erectile dysfunction
34. Testosterone and depression in aging men
35. Bioavailable testosterone and depression mood in older men: The Rancho Bernardo study
36. Testosterone replacement therapy for hypogonadal men with SSRI-refractory depression
37. Testosterone supplementation in the aging male
38. Elderly people's definitions of quality of life
39. Quality of life in chronic illness
40. Total cholesterol and high-density lipoprotein cholesterol as important predictors of erectile dysfunction
41. Effects of aging and diseases on male sexual function assessed by International Index of Erectile Function
42. Impotence and aging: Clinical and hormonal factors
43. The influence of medication on erectile function
44. The relationship between depressive symptoms and male erectile dysfunction: Cross-sectional results from the Massachusetts Male Aging Study
45. The predictive significance of patient-reported sexual functioning in RigiScan sleep evaluations
46. Sexual dysfunction and cardiac risk: Is depression a contributing factor?
47. Increased incidence of depressive symptoms in men with erectile dysfunction
48. Coronary heart disease and depression in the elderly - A population-based study
49. The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction
50. Major depressive disorder predicts cardiac events in patients with coronary artery disease
51. The nature and course of depression following myocardial infarction
52. Depression following myocardial infarction. Impact on 6 month survival
53. Depression and risk of coronary heart disease in the Normative Aging Study
54. The relationship of depression to cardiovascular disease
55. Treating the depressed patients with cardiovascular problems
56. Impotence and it medical and psychological correlates: Results of the Massachusetts Male Aging Study
57. Reports at European Urology Congress reflect issues of interest to aging men
58. Relative importance of sexuality and quality of life in patients with prostatic symptoms. Results of an international study
59. The evaluation of sexual function in men presenting with symptomatic benign prostatic hyperplasia
60. Erectile dysfunction following treatments of benign prostatic hyperplasia: A prospective study
61. Sexual function one year after transurethral prostatic resection. Patients' own assessments
62. Relationship between benign prostatic hyperplasia and history of coronary artery disease in elderly men
63. The epidemiology of benign prostatic hyperplasia and observations on concomitant hypertension
64. Role of the sympathetic nervous system in hypertension and benign prostatic hyperplasia
65. Benign prostatic hyperplasia: Natural evolution versus medical treatment
66. Alpha-adrenergic blocking drugs in the management of benign prostatic hyperplasia: Interactions with antihypertensive therapy
67. Incidence of acute myocardial infarction and cause-specific mortality after transurethral treatments of prostatic hypertrophy
68. Long-term incidence of acute myocardial infarction after open and transurethral resection of the prostate for benign prostatic hyperplasia
69. Nitric oxide based influence of nitrates on micturition in patients with benign prostatic hyperplasia
70. Invasive diagnosis and therapy - Are they still reasonable in the age of sildenafil?
71. Self-esteem and depression in men who present with erectile dysfunction
72. Health outcomes and quality of life
73. Results of an epidemiological survey in 3,500 French men aged 50 to 80 years with a special attention to urinary symptoms, quality of life and sexual function
74. An investigation into the relationship between BPH and male erectile dysfunction
75. Age but not urinary symptoms, prostate volume or obstruction determines sexual function in elderly men with lower urinary tract symptoms